The MM+M Podcast 9.9.2020: Alexion Pharmaceuticals’ Tamar Thompson
Tamar Thompson, VP of government affairs and policy at Alexion Pharmaceuticals, speaks about how the biotech company has evolved on the D&I front.
Biotech
We’ve got your 2019 pharma marketing milestones right here
Marketers and consultants across biopharma, med-tech and agency recall the marketing milestones that defined the past year.
Caris Life Sciences names Srikant Ramaswami chief communications officer
Ramaswami was most recently at rbb Communications and spent much of his career in pharma, including roles at J&J, Pfizer, and Merck.
John Jorden, Amgen
John Jorden is executive director, Amgen Digital Health at Amgen.
Jay Appel, Bristol-Myers Squibb
Jay Appel is executive director of Bristol-Myers Squibb.
Interview | Hans Kaspersetz, Arteric
Is technology causing agencies to become more specialized? Is there still a need for the human connection?
Five things for pharma marketers to know: Wednesday, January 24, 2018
Novartis sees single-digit growth with new CEO; J&J takes $13.6b charge in the wake of the new tax law; New York City invests in biotech
Five things for pharma marketers to know: Wednesday, January 17, 2018
Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer
Five things for pharma marketers to know: Friday, January 12, 2018
Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds
